Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
CJC-1295 and Ipamorelin act systemically by raising growth hormone and IGF-1
It has been studied in clinical trials involving over 2,000 individuals, is approved for use in over 30 countries (primarily for hepatitis and cancer immunotherapy), and has specific published research in autoimmune populations including RA, SLE, and MS patients
If pregnant, consult healthcare practitioner before use
It's currently labeled as a category 2 substance, meaning that the FDA has identified an ingredient as having a possible safety risk and it cannot be used in compounded medications
US$ 26.82
US$ 21.02
US$ 20.20
US$ 22.67
US$ 20.87
US$ 26.00
US$ 26.24
